SPONSOR
R3 Vascular Inc.
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Peripheral Arterial DiseaseAtherosclerotic LesionLower Extremity IschemiaLower Extremity ClaudicationCritical Limb-Threatening IschemiaCritical Limb IschemiaCritical Lower Limb Ischemia
R3 Vascular Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia, Lower Extremity Claudication.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — R3 Vascular Inc.
How many clinical trials has R3 Vascular Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by R3 Vascular Inc., of which 2 are actively recruiting participants. These trials cover conditions including Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does R3 Vascular Inc. research focus on?
R3 Vascular Inc. clinical trials span Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia, Lower Extremity Claudication, Critical Limb-Threatening Ischemia, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a R3 Vascular Inc. clinical trial?
To participate in a R3 Vascular Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all R3 Vascular Inc. trials with current recruitment status updated daily.
Clinical Trials by R3 Vascular Inc.
NCT04912323
Recruiting
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
Peripheral Arterial Disease
NCT06075940
Recruiting
Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia
Critical Limb-Threatening Ischemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology